Name: Miratyle S 50/5 Tablet (Mirabegron 50mg + Solifenacin 5mg)
Brand: Miratyle S 50/5 Tablet
Rating: 4.8 (150 reviews)

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

Mirabegron 50mg + Solifenacin 5mg at the best price in PCD Pharma Franchise for Beta-3 Agonist and Overactive Bladder Treatment.

Mirabegron 50mg + Solifenacin 5mg at the best price in Pharma Manufacturing for Beta-3 Agonist and Overactive Bladder Treatment

Mirabegron 50mg + Solifenacin 5mg at the best price in Pharma Export Company in India for Beta-3 Agonist and Overactive Bladder Treatment.

Mirabegron 50mg + Solifenacin 5mg at the best price in Top Pharma Company for Beta-3 Agonist and Overactive Bladder Treatment.

Miratyle S 50/5 Tablet at the best price in Urology pharma Franchise Franchise

Miratyle S 50/5 Tablet

Composition : Mirabegron (50mg) + Solifenacin (5mg)

Dosage Form : Tablet

Packaging Type :

Packaging :

Price : ₹1/-

Please Contact For Best Price

Miratyle S 50/5 Tablet is a combination medication containing Mirabegron (50mg) and Solifenacin (5mg), designed to provide a comprehensive solution for the treatment of overactive bladder (OAB) symptoms. This formulation combines two different classes of medications, each contributing to the reduction of OAB symptoms, such as urinary urgency, frequency, and incontinence.

Mirabegron is a beta-3 adrenergic agonist that works by relaxing the bladder’s detrusor muscle, which increases bladder capacity and reduces the involuntary contractions that lead to urinary urgency.
Solifenacin is an antimuscarinic agent that helps by blocking certain receptors in the bladder, reducing muscle spasms and further relieving symptoms associated with OAB.

Together, these two active ingredients target different mechanisms in the bladder, offering enhanced symptom control for patients with OAB who need both muscle relaxation and inhibition of bladder spasms.

This combination therapy is particularly beneficial for patients who have not responded adequately to other OAB treatments or for those who experience multiple symptoms that require a more comprehensive approach. The combination of Mirabegron and Solifenacin provides a unique mechanism of action that helps achieve better control of bladder function and an improved quality of life for OAB sufferers.

About the Product

Mirabegron is a beta-3 adrenergic agonist that works by relaxing the bladder’s detrusor muscle, which increases bladder capacity and reduces the involuntary contractions that lead to urinary urgency.
Solifenacin is an antimuscarinic agent that helps by blocking certain receptors in the bladder, reducing muscle spasms and further relieving symptoms associated with OAB.

Common side effects include: Dry mouth Constipation Blurred vision Headache Increased blood pressure Serious side effects are rare but may include: Urinary retention Cognitive disturbances Severe allergic reactions (rash, swelling, breathing difficulties) Consult your healthcare provider if any of these side effects become severe or persistent.

Treatment of overactive bladder (OAB) symptoms such as urinary urgency, frequency, and incontinence in adults. Ideal for patients who need dual therapy to manage OAB effectively.

Use under the supervision of a healthcare provider. Not recommended for individuals with uncontrolled hypertension or those with a history of urinary retention. May cause dizziness or blurred vision; exercise caution when performing tasks that require alertness. Regular monitoring of blood pressure and kidney function is recommended during treatment.